Clicky

Johnson & Johnson(JNJ)

Description: Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company has a collaboration agreement with Stand Up To Cancer for research testing a combination of teclistamab and daratumumab to treat a rare disease AL amyloidosis. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.


Keywords: Cancer Diabetes Surgery Infectious Diseases Health Care Prostate Cancer Neuroscience Rheumatoid Arthritis Psoriasis Lung Cancer Schizophrenia Macular Degeneration Inflammatory Bowel Disease Cataracts Bladder Cancer Pulmonary Arterial Hypertension Psoriatic Arthritis Hematologic Malignancies HIV/Aids General Surgery Neurodegenerative Disorders Pulmonary Hypertension Thrombosis Contact Lenses Zimmer Biomet Robotics Johnson Cataract Surgery Mood Disorders Johnson & Johnson Daratumumab Electrophysiology Products Healthcare Field Hemorrhagic And Ischemic Stroke Heart Rhythm Disorders

Home Page: www.jnj.com

One Johnson & Johnson Plaza
New Brunswick, NJ 08933
United States
Phone: 732 524 0400


Officers

Name Title
Mr. Joaquin Duato CEO & Chairman
Dr. Peter M. Fasolo Ph.D. Executive VP & Chief Human Resources Officer
Ms. Jennifer L. Taubert Executive VP & Worldwide Chairman of Innovative Medicine
Dr. John C. Reed M.D., Ph.D. Executive Vice President of Innovative Medicine, R&D
Mr. Robert J. Decker Jr. Controller & Chief Accounting Officer
Mr. James Swanson Executive VP & Chief Information Officer
Ms. Jessica Moore Vice President of Investor Relations
Mr. Dirk Brinckman Chief Compliance Officer
Ms. Elizabeth Forminard J.D. Executive VP & Chief Legal Officer
Dr. Guy J. Lebeau M.D. Group Chairman of MD&D Business - EMEA

Exchange: XETRA

Country: DE : Germany

Currency: Euro (€)

Forward PE: 13.947
Trailing PE: 24.5217
Price-to-Book MRQ: 5.1219
Price-to-Sales TTM: 3.905
IPO Date:
Fiscal Year End: December
Full Time Employees: 131900
Back to stocks